ACTA1 and steatosis: Specifically, Exp-gel reduced ROS accumulation, as evidenced by decreased nitrotyrosine staining, minimized fibrosis through reduced αSMA staining, and restored liver architecture, including decreased steatosis and inflammation, compared to the Con-gel controls (Figure 5D).